Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus
Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular glutamate concentration in the brain. Although studies from ours showed the effects of EtOH exposure on key glial glutamate transporters, little is known about the effects of sequential exposure to EtOH and MA o...
Gespeichert in:
Veröffentlicht in: | Journal of molecular neuroscience 2017-03, Vol.61 (3), p.343-350 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 350 |
---|---|
container_issue | 3 |
container_start_page | 343 |
container_title | Journal of molecular neuroscience |
container_volume | 61 |
creator | Alshehri, Fahad S. Althobaiti, Yusuf S. Sari, Youssef |
description | Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular glutamate concentration in the brain. Although studies from ours showed the effects of EtOH exposure on key glial glutamate transporters, little is known about the effects of sequential exposure to EtOH and MA or MA alone on certain glial glutamate transporters. In this study, we investigated the effects of sequential exposure to EtOH and MA on the expression of the major glutamate transporters, glutamate transporter 1 (GLT-1), as well as cystine/glutamate antiporter (xCT) and glutamate aspartate transporter (GLAST) in striatum and hippocampus. We also tested the effects of ceftriaxone (CEF), known to upregulate GLT-1, in animals administered EtOH and MA. Wistar rats were orally gavaged with EtOH (6 g/kg) or water for 7 days. On the following day (day 8), the rats received four intraperitoneal (i.p.) injections of MA (10 mg/kg) or saline (vehicle) occurring every 2 h. The rats were then treated with CEF (200 mg/kg/day, i.p.) or saline on days 8, 9, and 10. EtOH or MA exposure caused a significant downregulation of GLT-1 expression as compared to control groups in striatum and hippocampus. Furthermore, sequential exposure of EtOH and MA caused a significant downregulation of GLT-1 expression as compared to either drug administered alone in both brain regions. Importantly, GLT-1 expression was restored following CEF treatment. There were no significant differences on xCT and GLAST expression in striatum and hippocampus between all groups. These findings demonstrated that sequential exposure to EtOH and MA has additive effect in downregulation of GLT-1 and this effect can be attenuated by CEF treatment. |
doi_str_mv | 10.1007/s12031-016-0859-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5346045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4319893641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-25c0eb44a52771a5fb90aa5ac224c6571e7c005b1d33f5ecf2efc69d58c3ecfe3</originalsourceid><addsrcrecordid>eNqNkU1rFTEUhoMotlZ_gBsJuHEzmmTyuRFKubZCRdC6DrmZM70pM8mYZAr-e3O9tVRBcJPk5Dzvm48XoZeUvKWEqHeFMtLTjlDZES1Mpx-hYyraglIpH6Njoo3otDTyCD0r5YYQRjnVT9ERU1rr3shjVDbjCL4WnEZ8OswhhlIhw4A3dedimrCLA_4ErZiXHVTXCMAp4vMpuKmNa9tyFfBVdrEsKTdxwSHiL67irzUHV9f5l8dFWJbkm8tanqMno5sKvLibT9C3D5urs4vu8vP5x7PTy84L0teOCU9gy7kTTCnqxLg1xDnhPGPcS6EoKE-I2NKh70cBfmQwemkGoX3fKuhP0PuD77JuZxg8xJrdZJccZpd_2OSC_bMTw85ep1srei4JF83gzZ1BTt9XKNXOoXiYJhchrcVSrakSXBDzHyjnhBnKVUNf_4XepDXH9hONUkIaYtSeogfK51RKhvH-3pTYffr2kL5t6dt9-lY3zauHD75X_I67AewAlNaK15AfHP1P15-whry_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875690977</pqid></control><display><type>article</type><title>Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Alshehri, Fahad S. ; Althobaiti, Yusuf S. ; Sari, Youssef</creator><creatorcontrib>Alshehri, Fahad S. ; Althobaiti, Yusuf S. ; Sari, Youssef</creatorcontrib><description>Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular glutamate concentration in the brain. Although studies from ours showed the effects of EtOH exposure on key glial glutamate transporters, little is known about the effects of sequential exposure to EtOH and MA or MA alone on certain glial glutamate transporters. In this study, we investigated the effects of sequential exposure to EtOH and MA on the expression of the major glutamate transporters, glutamate transporter 1 (GLT-1), as well as cystine/glutamate antiporter (xCT) and glutamate aspartate transporter (GLAST) in striatum and hippocampus. We also tested the effects of ceftriaxone (CEF), known to upregulate GLT-1, in animals administered EtOH and MA. Wistar rats were orally gavaged with EtOH (6 g/kg) or water for 7 days. On the following day (day 8), the rats received four intraperitoneal (i.p.) injections of MA (10 mg/kg) or saline (vehicle) occurring every 2 h. The rats were then treated with CEF (200 mg/kg/day, i.p.) or saline on days 8, 9, and 10. EtOH or MA exposure caused a significant downregulation of GLT-1 expression as compared to control groups in striatum and hippocampus. Furthermore, sequential exposure of EtOH and MA caused a significant downregulation of GLT-1 expression as compared to either drug administered alone in both brain regions. Importantly, GLT-1 expression was restored following CEF treatment. There were no significant differences on xCT and GLAST expression in striatum and hippocampus between all groups. These findings demonstrated that sequential exposure to EtOH and MA has additive effect in downregulation of GLT-1 and this effect can be attenuated by CEF treatment.</description><identifier>ISSN: 0895-8696</identifier><identifier>EISSN: 1559-1166</identifier><identifier>DOI: 10.1007/s12031-016-0859-8</identifier><identifier>PMID: 27888396</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; Brain ; Ceftriaxone - pharmacology ; Cell Biology ; Central Nervous System Depressants - pharmacology ; Central Nervous System Stimulants - pharmacology ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; Dopamine ; Drug dosages ; Ethanol ; Ethanol - pharmacology ; Glutamate Plasma Membrane Transport Proteins - genetics ; Glutamate Plasma Membrane Transport Proteins - metabolism ; Hippocampus - drug effects ; Hippocampus - metabolism ; Laboratories ; Male ; Methamphetamine ; Methamphetamine - pharmacology ; Neurochemistry ; Neuroglia - drug effects ; Neuroglia - metabolism ; Neurology ; Neurosciences ; Pharmacy ; Proteomics ; Rats ; Rats, Wistar</subject><ispartof>Journal of molecular neuroscience, 2017-03, Vol.61 (3), p.343-350</ispartof><rights>Springer Science+Business Media New York 2016</rights><rights>Journal of Molecular Neuroscience is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-25c0eb44a52771a5fb90aa5ac224c6571e7c005b1d33f5ecf2efc69d58c3ecfe3</citedby><cites>FETCH-LOGICAL-c503t-25c0eb44a52771a5fb90aa5ac224c6571e7c005b1d33f5ecf2efc69d58c3ecfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12031-016-0859-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12031-016-0859-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27888396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alshehri, Fahad S.</creatorcontrib><creatorcontrib>Althobaiti, Yusuf S.</creatorcontrib><creatorcontrib>Sari, Youssef</creatorcontrib><title>Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus</title><title>Journal of molecular neuroscience</title><addtitle>J Mol Neurosci</addtitle><addtitle>J Mol Neurosci</addtitle><description>Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular glutamate concentration in the brain. Although studies from ours showed the effects of EtOH exposure on key glial glutamate transporters, little is known about the effects of sequential exposure to EtOH and MA or MA alone on certain glial glutamate transporters. In this study, we investigated the effects of sequential exposure to EtOH and MA on the expression of the major glutamate transporters, glutamate transporter 1 (GLT-1), as well as cystine/glutamate antiporter (xCT) and glutamate aspartate transporter (GLAST) in striatum and hippocampus. We also tested the effects of ceftriaxone (CEF), known to upregulate GLT-1, in animals administered EtOH and MA. Wistar rats were orally gavaged with EtOH (6 g/kg) or water for 7 days. On the following day (day 8), the rats received four intraperitoneal (i.p.) injections of MA (10 mg/kg) or saline (vehicle) occurring every 2 h. The rats were then treated with CEF (200 mg/kg/day, i.p.) or saline on days 8, 9, and 10. EtOH or MA exposure caused a significant downregulation of GLT-1 expression as compared to control groups in striatum and hippocampus. Furthermore, sequential exposure of EtOH and MA caused a significant downregulation of GLT-1 expression as compared to either drug administered alone in both brain regions. Importantly, GLT-1 expression was restored following CEF treatment. There were no significant differences on xCT and GLAST expression in striatum and hippocampus between all groups. These findings demonstrated that sequential exposure to EtOH and MA has additive effect in downregulation of GLT-1 and this effect can be attenuated by CEF treatment.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain</subject><subject>Ceftriaxone - pharmacology</subject><subject>Cell Biology</subject><subject>Central Nervous System Depressants - pharmacology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>Dopamine</subject><subject>Drug dosages</subject><subject>Ethanol</subject><subject>Ethanol - pharmacology</subject><subject>Glutamate Plasma Membrane Transport Proteins - genetics</subject><subject>Glutamate Plasma Membrane Transport Proteins - metabolism</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Laboratories</subject><subject>Male</subject><subject>Methamphetamine</subject><subject>Methamphetamine - pharmacology</subject><subject>Neurochemistry</subject><subject>Neuroglia - drug effects</subject><subject>Neuroglia - metabolism</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Pharmacy</subject><subject>Proteomics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0895-8696</issn><issn>1559-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU1rFTEUhoMotlZ_gBsJuHEzmmTyuRFKubZCRdC6DrmZM70pM8mYZAr-e3O9tVRBcJPk5Dzvm48XoZeUvKWEqHeFMtLTjlDZES1Mpx-hYyraglIpH6Njoo3otDTyCD0r5YYQRjnVT9ERU1rr3shjVDbjCL4WnEZ8OswhhlIhw4A3dedimrCLA_4ErZiXHVTXCMAp4vMpuKmNa9tyFfBVdrEsKTdxwSHiL67irzUHV9f5l8dFWJbkm8tanqMno5sKvLibT9C3D5urs4vu8vP5x7PTy84L0teOCU9gy7kTTCnqxLg1xDnhPGPcS6EoKE-I2NKh70cBfmQwemkGoX3fKuhP0PuD77JuZxg8xJrdZJccZpd_2OSC_bMTw85ep1srei4JF83gzZ1BTt9XKNXOoXiYJhchrcVSrakSXBDzHyjnhBnKVUNf_4XepDXH9hONUkIaYtSeogfK51RKhvH-3pTYffr2kL5t6dt9-lY3zauHD75X_I67AewAlNaK15AfHP1P15-whry_</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Alshehri, Fahad S.</creator><creator>Althobaiti, Yusuf S.</creator><creator>Sari, Youssef</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170301</creationdate><title>Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus</title><author>Alshehri, Fahad S. ; Althobaiti, Yusuf S. ; Sari, Youssef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-25c0eb44a52771a5fb90aa5ac224c6571e7c005b1d33f5ecf2efc69d58c3ecfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain</topic><topic>Ceftriaxone - pharmacology</topic><topic>Cell Biology</topic><topic>Central Nervous System Depressants - pharmacology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>Dopamine</topic><topic>Drug dosages</topic><topic>Ethanol</topic><topic>Ethanol - pharmacology</topic><topic>Glutamate Plasma Membrane Transport Proteins - genetics</topic><topic>Glutamate Plasma Membrane Transport Proteins - metabolism</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Laboratories</topic><topic>Male</topic><topic>Methamphetamine</topic><topic>Methamphetamine - pharmacology</topic><topic>Neurochemistry</topic><topic>Neuroglia - drug effects</topic><topic>Neuroglia - metabolism</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Pharmacy</topic><topic>Proteomics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alshehri, Fahad S.</creatorcontrib><creatorcontrib>Althobaiti, Yusuf S.</creatorcontrib><creatorcontrib>Sari, Youssef</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alshehri, Fahad S.</au><au>Althobaiti, Yusuf S.</au><au>Sari, Youssef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus</atitle><jtitle>Journal of molecular neuroscience</jtitle><stitle>J Mol Neurosci</stitle><addtitle>J Mol Neurosci</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>61</volume><issue>3</issue><spage>343</spage><epage>350</epage><pages>343-350</pages><issn>0895-8696</issn><eissn>1559-1166</eissn><abstract>Exposure to ethanol (EtOH) or methamphetamine (MA) can lead to increase in extracellular glutamate concentration in the brain. Although studies from ours showed the effects of EtOH exposure on key glial glutamate transporters, little is known about the effects of sequential exposure to EtOH and MA or MA alone on certain glial glutamate transporters. In this study, we investigated the effects of sequential exposure to EtOH and MA on the expression of the major glutamate transporters, glutamate transporter 1 (GLT-1), as well as cystine/glutamate antiporter (xCT) and glutamate aspartate transporter (GLAST) in striatum and hippocampus. We also tested the effects of ceftriaxone (CEF), known to upregulate GLT-1, in animals administered EtOH and MA. Wistar rats were orally gavaged with EtOH (6 g/kg) or water for 7 days. On the following day (day 8), the rats received four intraperitoneal (i.p.) injections of MA (10 mg/kg) or saline (vehicle) occurring every 2 h. The rats were then treated with CEF (200 mg/kg/day, i.p.) or saline on days 8, 9, and 10. EtOH or MA exposure caused a significant downregulation of GLT-1 expression as compared to control groups in striatum and hippocampus. Furthermore, sequential exposure of EtOH and MA caused a significant downregulation of GLT-1 expression as compared to either drug administered alone in both brain regions. Importantly, GLT-1 expression was restored following CEF treatment. There were no significant differences on xCT and GLAST expression in striatum and hippocampus between all groups. These findings demonstrated that sequential exposure to EtOH and MA has additive effect in downregulation of GLT-1 and this effect can be attenuated by CEF treatment.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27888396</pmid><doi>10.1007/s12031-016-0859-8</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-8696 |
ispartof | Journal of molecular neuroscience, 2017-03, Vol.61 (3), p.343-350 |
issn | 0895-8696 1559-1166 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5346045 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Biomedical and Life Sciences Biomedicine Brain Ceftriaxone - pharmacology Cell Biology Central Nervous System Depressants - pharmacology Central Nervous System Stimulants - pharmacology Corpus Striatum - drug effects Corpus Striatum - metabolism Dopamine Drug dosages Ethanol Ethanol - pharmacology Glutamate Plasma Membrane Transport Proteins - genetics Glutamate Plasma Membrane Transport Proteins - metabolism Hippocampus - drug effects Hippocampus - metabolism Laboratories Male Methamphetamine Methamphetamine - pharmacology Neurochemistry Neuroglia - drug effects Neuroglia - metabolism Neurology Neurosciences Pharmacy Proteomics Rats Rats, Wistar |
title | Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T16%3A00%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Administered%20Ethanol%20and%20Methamphetamine%20on%20Glial%20Glutamate%20Transporters%20in%20Rat%20Striatum%20and%20Hippocampus&rft.jtitle=Journal%20of%20molecular%20neuroscience&rft.au=Alshehri,%20Fahad%20S.&rft.date=2017-03-01&rft.volume=61&rft.issue=3&rft.spage=343&rft.epage=350&rft.pages=343-350&rft.issn=0895-8696&rft.eissn=1559-1166&rft_id=info:doi/10.1007/s12031-016-0859-8&rft_dat=%3Cproquest_pubme%3E4319893641%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875690977&rft_id=info:pmid/27888396&rfr_iscdi=true |